select a format

Single User License
USD 250 INR 16230
Site License
USD 500 INR 32460
Corporate User License
USD 750 INR 48690

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Ono Pharmaceutical Co Ltd (4528)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Ono Pharmaceutical Co Ltd (4528)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH31988D
  • |
  • Pages: 65
  • |
  • July 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a research-based pharmaceutical company, which carries out the discovery, production and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer's disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others. Ono Pharmaceutical also has many other products in pipeline development. The company offers products in various formulations such as capsules, tablets, injections, patches, dry syrup and intravenous infusion. It has operational presence in Japan, Taiwan, South Korea, the UK and the US. Ono Pharmaceutical is headquartered in Chuo-ku, Osaka, Japan.

Ono Pharmaceutical Co Ltd (4528)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 6

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

Ono Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 12

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 17

Partnerships 17

Receptos Expands Collaboration With Ono Pharma For GPCR Technology Platform 17

Seikagaku Enters into Partnership with Ono Pharmaceutical 18

Numab Therapeutics Enters into Research and Option Agreement with Ono Pharma 19

X-Chem Enters into Agreement with Ono Pharma 19

Takeda Pharma and Shionogi Enter into Research Agreement with Sumitomo Dainippon Pharma, Ono Pharma and Mitsubishi Tanabe Pharma 20

Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter into Agreemet with Four Research Institutions 21

Ono Pharma Enters into Development Agreement with China Chemical & Pharma for Limaprost Alfadex 23

Dako Enters into Development Agreement with ONO PHARMA for Opdivo 24

Ono Pharma Enters into Development Agreement with Meiji Seika for Limaprost Alfadex 25

Bristol-Myers Squibb Enters into Co-Development Agreement with Ono Pharma 26

AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 27

Ono Pharma Expands Co -Development Agreement With Dainippon Sumitomo Pharma For Limaprost Alfadex 28

Ono Pharma Enters Into Drug Discovery Agreement With Domain Therapeutics 29

Ono Pharma Enters Into Discovery Agreement With BioFocus For CNS Drugs 30

Ono Pharma Enters Into Drug Discovery Agreement With BioFocus 31

Ono Pharma Enters Into Co-Development Agreement With Scil Proteins For Affilin Therapeutics 31

Receptos Enters Into R&D Agreement With Ono Pharma 32

Progenra Enters Into Research Agreement With Ono Pharma 33

Bristol-Myers Squibb Expands Co-Development Agreement With Ono Pharma 34

Bristol-Myers Squibb Enters Into Co-Development Agreement With Ono Pharma For ORENCIA 36

Ono Pharma Extends Research Agreement With Evotec 37

Ono Pharma Enters Into Agreement With Dainippon Sumitomo For Limaprost Alfadex 38

Xention Extends Collaboration With Ono Pharma 39

Ono Pharma Enters Into Co-Development Agreement With BioFocus 40

Licensing Agreements 40

Ono Pharma Enters into Licensing Agreement with Array BioPharma 40

Merck Enters into Licensing Agreement with Bristol-Myers Squibb and Ono Pharma 41

Ono Pharma Enters into Licensing Agreement with Ligand Pharma 43

ONO Pharma Enters into Licensing Agreement with IDAC Theranostics 43

ONO Pharma Enters into Licensing Agreement with Celyad 44

Santen Pharma Enters into Licensing Agreement with Ono Pharma 45

Ono Pharma Enters into Licensing Agreement with Gilead Sciences for ONO-4059 46

Ono Pharma Enters into Licensing Agreement with Merus 47

Ono Pharma Enters Into Licensing Agreement With Bial For BIA 9-1067 48

Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 49

Merck Serono Enters Into Licensing Agreement With Ono Pharma For ONO-4641 49

Merck Serono Enters Into Licensing Agreement With Ono Pharma For Stimuvax 51

Ono Pharma Enters Into Licensing Agreement With KAI Pharma For KAI-4169 52

Ono Pharma Enters Into Licensing Agreement With Les Laboratoires Servier For Ivabradine 52

Ono Pharma Enters Into Licensing Agreement With OncoTherapy 54

Ono Pharmaceutical Co Ltd-Key Competitors 55

Key Employees 56

Locations And Subsidiaries 58

Head Office 58

Other Locations & Subsidiaries 58

Recent Developments 60

Strategy And Business Planning 60

Mar 01, 2016: Completion of the new Research Building (The Third Building) in the Minase Research Institute 60

Financial Announcements 61

Dec 21, 2016: ONO PHARMACEUTICAL: Revisions of Consolidated Financial Forecasts 61

Government and Public Interest 62

Jul 27, 2016: Infusion of Nearly $35.4 Million in Grant Funding to Support Roswell Park Research 62

Product News 64

Jan 26, 2016: ONO PHARMACEUTICAL Selects Medidata to Power Clinical Trials Exploring Additional Cancer Indications for Immunotherapy Drug OPDIVO 64

Appendix 65

Methodology 65

About GlobalData 65

Contact Us 65

Disclaimer 65

List of Figures

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

Ono Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 12

List of Tables

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 1

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Ono Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 10

Ono Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 12

Ono Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13

Receptos Expands Collaboration With Ono Pharma For GPCR Technology Platform 17

Seikagaku Enters into Partnership with Ono Pharmaceutical 18

Numab Therapeutics Enters into Research and Option Agreement with Ono Pharma 19

X-Chem Enters into Agreement with Ono Pharma 19

Takeda Pharma and Shionogi Enter into Research Agreement with Sumitomo Dainippon Pharma, Ono Pharma and Mitsubishi Tanabe Pharma 20

Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter into Agreemet with Four Research Institutions 21

Ono Pharma Enters into Development Agreement with China Chemical & Pharma for Limaprost Alfadex 23

Dako Enters into Development Agreement with ONO PHARMA for Opdivo 24

Ono Pharma Enters into Development Agreement with Meiji Seika for Limaprost Alfadex 25

Bristol-Myers Squibb Enters into Co-Development Agreement with Ono Pharma 26

AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 27

Ono Pharma Expands Co -Development Agreement With Dainippon Sumitomo Pharma For Limaprost Alfadex 28

Ono Pharma Enters Into Drug Discovery Agreement With Domain Therapeutics 29

Ono Pharma Enters Into Discovery Agreement With BioFocus For CNS Drugs 30

Ono Pharma Enters Into Drug Discovery Agreement With BioFocus 31

Ono Pharma Enters Into Co-Development Agreement With Scil Proteins For Affilin Therapeutics 31

Receptos Enters Into R&D Agreement With Ono Pharma 32

Progenra Enters Into Research Agreement With Ono Pharma 33

Bristol-Myers Squibb Expands Co-Development Agreement With Ono Pharma 34

Bristol-Myers Squibb Enters Into Co-Development Agreement With Ono Pharma For ORENCIA 36

Ono Pharma Extends Research Agreement With Evotec 37

Ono Pharma Enters Into Agreement With Dainippon Sumitomo For Limaprost Alfadex 38

Xention Extends Collaboration With Ono Pharma 39

Ono Pharma Enters Into Co-Development Agreement With BioFocus 40

Ono Pharma Enters into Licensing Agreement with Array BioPharma 40

Merck Enters into Licensing Agreement with Bristol-Myers Squibb and Ono Pharma 41

Ono Pharma Enters into Licensing Agreement with Ligand Pharma 43

ONO Pharma Enters into Licensing Agreement with IDAC Theranostics 43

ONO Pharma Enters into Licensing Agreement with Celyad 44

Santen Pharma Enters into Licensing Agreement with Ono Pharma 45

Ono Pharma Enters into Licensing Agreement with Gilead Sciences for ONO-4059 46

Ono Pharma Enters into Licensing Agreement with Merus 47

Ono Pharma Enters Into Licensing Agreement With Bial For BIA 9-1067 48

Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 49

Merck Serono Enters Into Licensing Agreement With Ono Pharma For ONO-4641 49

Merck Serono Enters Into Licensing Agreement With Ono Pharma For Stimuvax 51

Ono Pharma Enters Into Licensing Agreement With KAI Pharma For KAI-4169 52

Ono Pharma Enters Into Licensing Agreement With Les Laboratoires Servier For Ivabradine 52

Ono Pharma Enters Into Licensing Agreement With OncoTherapy 54

Ono Pharmaceutical Co Ltd, Key Competitors 55

Ono Pharmaceutical Co Ltd, Key Employees 56

Ono Pharmaceutical Co Ltd, Other Locations 58

Ono Pharmaceutical Co Ltd, Subsidiaries 58

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Ono Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com